FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

CUSIP: 31447P100

Q2 2018 13F Holders as of 30 Jun 2018

Holder snapshot 6 signals
Share change
+1,768,938
SEC-reported price per share
$10.44
Indexed holders
43
Value change
+$18,177,598
Number of buys
33
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
34,958,098

Security key

31447P100

Report period

Q2 2018

Indexed institutions

43

Top holders

10

Ownership snapshot

Top reported holders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Southpoint Capital Adviso...
Disclosed value leader
Southpoint Capital Adviso...
Comparable rows
0/15
Latest evidence
31 Mar 2018
13F Highest disclosed value: $48,346,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Southpoint Capital Advisors LP has the largest disclosed position value at $48.35M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Southpoint Capital Advisors LP's linked filing trail.
Disclosed position value Top 5
Southpoint Capital Advisors LP $48.35M
Opaleye Management Inc. $10.56M
683 Capital Management, LLC $10.49M
EVENTIDE ASSET MANAGEMENT, LLC $8.96M
Avoro Capital Advisors LLC $3.28M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Southpoint Capital Advisors LP
13F
Company
13F
—
denominator unverified
$48,346,000
3,997,214 shares
— 31 Mar 2018
Opaleye Management Inc.
13F
Company
13F
—
denominator unverified
$10,559,000
873,000 shares
— 31 Mar 2018
683 Capital Management, LLC
13F
Company
13F
—
denominator unverified
$10,489,000
867,185 shares
— 31 Mar 2018
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$8,961,000
741,175 shares
— 31 Mar 2018
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$3,284,000
272,666 shares
— 31 Mar 2018
PUTNAM INVESTMENTS LLC
13F
Company
13F
—
denominator unverified
$3,185,000
263,433 shares
— 31 Mar 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
43
Shares
9,392,799
Indexed holders
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 indexed holders
21
Q2 2018 indexed holders
43
Indexed holder difference
22
Investor Q1 2018 Shares Q2 2018 Shares Share Diff Share Chg % Q1 2018 value Q2 2018 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .